I am not thinking that - but you asked for an explanation of riskyrider’s post and as I understand where s/he‘s coming from I just answered your question.
It’s the nature of innovation that something better than paxalisib will come along at some point. I can only hope that for patients with GBM because the paxalisib Phase II interim data, as good as it is vs. SOC, is far from a cure for them.